公司问答丨华特达因：公司代理的褪黑素颗粒于年初上市以来入院及销售工作按照公司推广计划正常推进

格隆汇08-24 15:41

有投资者在互动平台向华特达因提问，请问贵公司代理的褪黑素颗粒医院端售卖情况如何？华特达因回复称，公司代理的褪黑素颗粒于年初上市以来入院及销售工作按照公司推广计划正常推进。作为重点针对精神障碍儿童的睡眠治疗的处方药，患者家长认知及应用需要一定推广过程，公司正积极开展相关疾病治疗及产品知识的宣传推广工作。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohunote.com/m/news/2661229582?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-08-24 15:41","share_image_url":"https://static.laohu8.com/6b8fa6424aebe95f6781d04ef17a1852","id":"2661229582","market":"sh","top_or_hot":-1,"title":"公司问答丨华特达因：公司代理的褪黑素颗粒于年初上市以来入院及销售工作按照公司推广计划正常推进","media":"格隆汇","content":"<html><body>有投资者在互动平台向华特达因提问，请问贵公司代理的褪黑素颗粒医院端售卖情况如何？华特达因回复称，公司代理的褪黑素颗粒于年初上市以来入院及销售工作按照公司推广计划正常推进。作为重点针对精神障碍儿童的睡眠治疗的处方药，患者家长认知及应用需要一定推广过程，公司正积极开展相关疾病治疗及产品知识的宣传推广工作。</body></html>","source":"live_gelonghui","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>公司问答丨华特达因：公司代理的褪黑素颗粒于年初上市以来入院及销售工作按照公司推广计划正常推进</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n公司问答丨华特达因：公司代理的褪黑素颗粒于年初上市以来入院及销售工作按照公司推广计划正常推进\n</h2>\n\n<h4 class=\"meta\">\n\n</h4>\n\n</header>\n<article>\n<html><body>有投资者在互动平台向华特达因提问，请问贵公司代理的褪黑素颗粒医院端售卖情况如何？华特达因回复称，公司代理的褪黑素颗粒于年初上市以来入院及销售工作按照公司推广计划正常推进。作为重点针对精神障碍儿童的睡眠治疗的处方药，患者家长认知及应用需要一定推广过程，公司正积极开展相关疾病治疗及产品知识的宣传推广工作。</body></html>\n\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.gelonghui.com/rss/live/live.xml\">格隆汇</a> </p>\n\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n</div>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0188","symbol_name":"融资融券","start_time":0,"source_url":"https://www.gelonghui.com/rss/live/live.xml","article_id":"2661229582","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2661229582","pubTimestamp":1787557309,"columns":[],"sourceInfo":{"source_id":"live_gelonghui","name":"格隆汇"},"weMediaInfo":null,"summary":"有投资者在互动平台向华特达因提问，请问贵公司代理的褪黑素颗粒医院端售卖情况如何？华特达因回复称，公司代理的褪黑素颗粒于年初上市以来入院及销售工作按照公司推广计划正常推进。作为重点针对精神障碍儿童的睡眠","collect":0,"end_time":0,"defaultTopTitle":"gelonghui.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK0188":"融资融券","BK0122":"高校","000915":"华特达因","BK0239":"医药制造","BK0186":"小盘成长","BK0175":"白马股"},"translate_title":"Company Q&A | Walter Dyne: The admission and sales of melatonin granules represented by the company have progressed normally according to the company's promotion plan since their listing at the beginning of the year","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"000915":1.5},"content_text":"有投资者在互动平台向华特达因提问，请问贵公司代理的褪黑素颗粒医院端售卖情况如何？华特达因回复称，公司代理的褪黑素颗粒于年初上市以来入院及销售工作按照公司推广计划正常推进。作为重点针对精神障碍儿童的睡眠治疗的处方药，患者家长认知及应用需要一定推广过程，公司正积极开展相关疾病治疗及产品知识的宣传推广工作。","kind":"live","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2661229582","isCrawlerRequest":true}